Learning from the global response to COVID‐19 to accelerate innovation in mental health trials Wiley
Psychiatric symptoms and cognitive impairment in “Long COVID”: the relevance of immunopsychiatry Wiley
Common medications accumulate in gut bacteria, which may reduce drug effectiveness and alter the gut microbiome Science Daily
Fluvoxamine, an antidepressant, could be an effective COVID-19 treatment The Edwardsville Intelligencer
Fluvoxamine, an antidepressant, could be an effective COVID-19 treatment The Pioneer
Fluvoxamine, an antidepressant, could be an effective COVID-19 treatment Alton Telegraph
Zydus Cadila receives tentative approval from USFDA for Brexpiprazole Tablets Equity Bulls
National Suicide Prevention Month: Should Antidepressants Be Routinely Listed as a Risk Factor for Suicide? EIN News
Ozark Center marks suicide-prevention observance with training, memorial Joplin Globe
Study finds accumulation of common therapeutic drugs by gut bacteria News-Medical.Net
